Rallybio Corp financial data

Symbol
RLYB on Nasdaq
Location
234 Church Street, Suite 1020, New Haven, CT
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.09K % +1.55%
Debt-to-equity 10.2 % -2.87%
Return On Assets -65.1 % +3.01%
Operating Margin -5.99K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 41.8M shares +0.72%
Common Stock, Shares, Outstanding 41.7M shares +0.53%
Entity Public Float 36.7M USD -72.7%
Common Stock, Value, Issued 4K USD 0%
Weighted Average Number of Shares Outstanding, Basic 44.8M shares +1.62%
Weighted Average Number of Shares Outstanding, Diluted 44.8M shares +1.62%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 725K USD -29.1%
Research and Development Expense 27.4M USD -50.2%
General and Administrative Expense 16.7M USD -25.6%
Operating Income (Loss) -43.4M USD +43.9%
Nonoperating Income (Expense) 3.69M USD -36.9%
Net Income (Loss) Attributable to Parent -41.7M USD +43.6%
Earnings Per Share, Basic 0 USD/shares +48.6%
Earnings Per Share, Diluted 0 USD/shares +48.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.45M USD -43.3%
Marketable Securities, Current 36.3M USD -49.5%
Cash, Cash Equivalents, and Short-term Investments 45.7M USD -48.4%
Other Assets, Current 573K USD -46.9%
Assets, Current 50.3M USD -45%
Property, Plant and Equipment, Net 61K USD -65.5%
Operating Lease, Right-of-Use Asset 51K USD -79.6%
Assets 51M USD -44.8%
Accounts Payable, Current 119K USD -90.2%
Accrued Liabilities, Current 4.23M USD -55.6%
Contract with Customer, Liability, Current 636K USD -47.1%
Liabilities, Current 5.04M USD -58.6%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 5.04M USD -59.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 17K USD
Retained Earnings (Accumulated Deficit) -312M USD -15.4%
Stockholders' Equity Attributable to Parent 46M USD -42.6%
Liabilities and Equity 51M USD -44.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.2M USD +34%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 11.1M USD +7.96%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 41.7M shares +0.53%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 876K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.45M USD -43.3%
Deferred Tax Assets, Valuation Allowance 98M USD +25.2%
Deferred Tax Assets, Gross 98M USD +25.2%
Operating Lease, Liability 154K USD -60.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -41.6M USD +43.6%
Lessee, Operating Lease, Liability, to be Paid 156K USD -61.6%
Property, Plant and Equipment, Gross 769K USD 0%
Operating Lease, Liability, Current 58K USD -74.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 156K USD -32.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2K USD -85.7%
Deferred Tax Assets, Operating Loss Carryforwards 46M USD +23.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Additional Paid in Capital 358M USD +2.14%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 7.48M USD -18.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%